Indications and uses
Helps prevent sunburn If used as directed with other sun protection measures (see directions) decreases the risk of skin cancer and early skin aging caused by the sun
Helps prevent sunburn If used as directed with other sun protection measures (see directions) decreases the risk of skin cancer and early skin aging caused by the sun
Apply in the morning over intensive serum as a moisturizing sunscreen. Smooth over face and neck, massaging in upward, outward, circular motions. Apply at least 15 minutes before sun exposure. Reapply every 2 hours if skin is being exposed to the sun. Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early signs of skin aging. To decrease this risk, regularly use a sunscreen ...
Protect this product from excessive heat and direct sun
Drug Facts
Octinoxate 5%
Avobenzone 3%
Octocrylene 8%
Sunscreen
For External use only
Do not use on damaged or broken skin
Stop use and ask a doctor if rash occurs
When using this product keep out of eyes. Rinse with water to remove.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Water, Cetearyl Alcohol, Isopropyl Palmitate, Ceteareth-20, Keratin, Hydrolyzed keratin, Glycerin, Sucrose Polybehenate, Gluconolactone, Sodium benzoate, Potassium sorbate, fragrance
Protect this product from excessive heat and direct sun
Manufactured in
New Zealand
for
Keraplast Technologies, LLC.
San Antonio, TX 78258
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24854-300-50 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d268-f6ea-e053-dbdaa90aa703 | Day Shield Broad Spectrum SPF 25 |
| 24854-400-50 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d268-f6ea-e053-dbdaa90aa703 | Day Shield Broad Spectrum SPF 25 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24854-300-50 | retrospect day shield broad spectrum SPF 25 | 50 mL in 1 BOTTLE, PUMP | LOTION | 50 | 1 | |
| 24854-300-50 | retrospect day shield broad spectrum SPF 25 | 1 in 1 CARTON | LOTION | 1 | 1 | |
| 24854-400-50 | keras day shield broad spectrum SPF 25 | 50 mL in 1 BOTTLE, PUMP | LOTION | 50 | 1 | |
| 24854-400-50 | keras day shield broad spectrum SPF 25 | 1 in 1 CARTON | LOTION | 1 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 24854-300 | KERAS DAY SHIELD BROAD SPECTRUM SPF 25 (OCTINOXATE, AVOBENZONE, AND OCTOCRYLENE) LOTION RETROSPECT DAY SHIELD BROAD SPECTRUM SPF 25 (OCTINOXATE, AVOBENZONE, AND OCTOCRYLENE) LOTION [KERAPLAST TECHNOLOGIES LLC] | 1 | Legacy NDC, 2 package rows | 20120330_1a784b0e-a517-4510-a547-1334febfc0aa.zip |
| 24854-400 | KERAS DAY SHIELD BROAD SPECTRUM SPF 25 (OCTINOXATE, AVOBENZONE, AND OCTOCRYLENE) LOTION RETROSPECT DAY SHIELD BROAD SPECTRUM SPF 25 (OCTINOXATE, AVOBENZONE, AND OCTOCRYLENE) LOTION [KERAPLAST TECHNOLOGIES LLC] | 1 | Legacy NDC, 2 package rows | 20120330_1a784b0e-a517-4510-a547-1334febfc0aa.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| avobenzone | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| cetostearyl alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| gluconolactone | INACTIVE INGREDIENT | WQ29KQ9POT | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| isopropyl palmitate | INACTIVE INGREDIENT | 8CRQ2TH63M | 1 | |
| polyoxyl 20 cetostearyl ether | INACTIVE INGREDIENT | YRC528SWUY | 1 | |
| potassium sorbate | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| sodium benzoate | INACTIVE INGREDIENT | OJ245FE5EU | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24854-400 | 24854-400-50 |
| 24854-300 | 24854-300-50 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | GEL / DENTAL | 0.08 %w/w | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | GEL / RECTAL | 406 mg | ||
| isopropyl palmitate | ISOPROPYL PALMITATE | 8CRQ2TH63M | AEROSOL / TOPICAL | 397 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | PASTE, DENTIFRICE / DENTAL | 0.5 %w/w | ||
| cetostearyl alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | TABLET, EXTENDED RELEASE / ORAL | 800 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| gluconolactone | GLUCONOLACTONE | WQ29KQ9POT | SOLUTION / TOPICAL | 0.3 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | CREAM / TOPICAL | 0.2 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / RECTAL | 6.67 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | 1 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| isopropyl palmitate | ISOPROPYL PALMITATE | 8CRQ2TH63M | GEL / TOPICAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION, EXTENDED RELEASE / ORAL | 24 mg | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, COATED / ORAL | NA | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | 320 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAVENOUS | 864 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| cetostearyl alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / TOPICAL | 1428 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | GRANULE, EFFERVESCENT / ORAL | 60 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| cetostearyl alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CAPSULE, EXTENDED RELEASE / ORAL | 9.43 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| gluconolactone | GLUCONOLACTONE | WQ29KQ9POT | INJECTION / INTRAVENOUS | ADJ PH | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAMUSCULAR | 864 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| gluconolactone | GLUCONOLACTONE | WQ29KQ9POT | CLOTH / TOPICAL | NA | ||
| isopropyl palmitate | ISOPROPYL PALMITATE | 8CRQ2TH63M | LOTION / TOPICAL | 5 %w/w | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 54e717a9-f442-48a5-8aac-eee89f00746d | 1a784b0e-a517-4510-a547-1334febfc0aa | 2011-11-30 | Warnings | 54e717a9-f442-48a5-8aac-eee89f00746d 1a784b0e-a517-4510-a547-1334febfc0aa |
Adverse event summaries are temporarily unavailable. Other product information remains available.